IRVINE, Calif., May 15, 2025 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Inc. (Nasdaq: SBC) has announced the approval of a share repurchase program, with the board authorizing a maximum aggregate amount of US $5 million. The repurchase is set to commence on May 20, 2025, and will continue until May 20, 2026, utilizing surplus cash and future free cash flow. The company aims to enhance shareholder value and address what it perceives as an undervaluation of its shares in the market.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.